News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • A novel pairing of two cancer drug types showed promising activity and had manageable toxicities, according to a first-of-its-kind clinical trial led by scientists at Dana-Farber Cancer Institute.

Tags: BreastCancer, OvarianCancer, GynecologicCancers

  • A Dana-Farber and Harvard School of Public Health study finds that most young women with breast cancer chose to have a mastectomy rather than a surgical procedure that would conserve the breast.

Tags: BreastCancer, PopulationScience

  • Dana-Farber scientists find when given together, two orally available experimental drugs – sapacitabine and seliciclib – worked together to elicit antitumor effects in patients with incurable BRCA-deficient cancers.

Tags: BasicResearch, BreastCancer, PancreaticCancer, GynecologicCancers

  • A new report showing that breast cancer patients treated with low doses of radiation therapy have a heightened risk of heart disease suggests that physicians need to work with patients before, during, and after treatment to minimize that risk.

Tags: BreastCancer, Radiation, Survivorship

  • Dana-Farber scientists have linked genetic variants to the regulation of genes involved in breast cancer, including four genes not previously implicated in breast cancer, shedding new insights into the biology of breast cancer.

Tags: BreastCancer, Genomics

  • Kornelia Polyak, MD, PhD, was presented with the 2012 AACR Outstanding Investigator Award for Breast Cancer Research at the 35th annual CTRC-AACR San Antonio Breast Cancer Symposium.

Tags: BasicResearch, BreastCancer, Honors

  • Wendy Chen, MD, MPH, a breast cancer expert at Dana-Farber Cancer Institute helps tackles some of the myths and misconceptions about breast cancer risk. She answers some of the more common questions, explains the studies behind the answers, and provides risk-lowering tips.

Tags: BreastCancer, Nutrition, PatientEducation, Prevention

  • Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."

Tags: BasicResearch, BreastCancer, Leukemia

  • Erica Mayer, MD, MPH, is a breast cancer expert at Dana-Farber. She says there are at least five simple ways women can reduce their risk of getting the disease.

Tags: BreastCancer, Genetics, Prevention

  • In one of the largest breast cancer sequencing efforts to date, scientists from Dana-Farber and their colleagues have discovered surprising alterations in genes that were not previously associated with breast cancer.

Tags: BasicResearch, BreastCancer, Genomics

Showing 21-30 of 54 items